STAT News

STAT+: Early results for Alterome’s KRAS drug for pancreas, lung and colon cancer arrive

Alterome presented preliminary Phase 1 results of its drug “selectively” targeting a range of KRAS mutations — drivers of cancers in the pancreas, lung and colon:

By STAT News

1 min read
STAT+: Early results for Alterome’s KRAS drug for pancreas, lung and colon cancer arrive
AI-generated illustration

Got news to share with the events industry?

Submit a press release or story tip and reach thousands of event professionals.

Get in touch→

More in Health Tech

Related Insights